Neurovance

Drug to modulate neurochemicals to treat Attention Deficit Hyperactivity Disorder .

placeCambridge, Massachusetts, United States calendar_todayFounded 2011 groups7 employees language neurovance.com

Innovation

7 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 797 times.

YearFilings
20131
20143
20154
20163
20173
20183
20212

Investor mix

5 investors on record; lead investors include Venture Investors, GBS, Novartis Venture Fund, Tekla Capital Management.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%
Coming soon